The Hidden Connection Between Heart Disease and Chronic Kidney Disease: What You Need to Know
Updated: 5 days ago
Written by Dr Saneka Chakravarty, MD, FACC. Dr Chakravarty is a board-certified cardiovascular disease specialist focused on personalized preventive cardiovascular care.
Did you know that if you have chronic kidney disease (CKD), heart disease becomes one of your biggest health risks? In fact, most people with CKD are more likely to die from heart-related complications than to reach kidney failure. The good news is that the same steps that protect your kidneys also protect your heart.
This article explains why CKD and heart disease are so closely linked, how one worsens the other, and the proven steps you can take to protect both.
Why Are Heart Disease and Chronic kidney disease (CKD) So Closely Connected?
The heart and kidneys work as a team. Your kidneys filter waste, help regulate blood pressure, and balance fluid, while your heart pumps blood to nourish every organ, including the kidneys. When one struggles, the other is put under strain (Sarnak et al., Journal of the American College of Cardiology, 2019).
1. Shared Risk Factors
Heart disease and CKD often grow from the same roots:
High blood pressure (hypertension) – damages both the heart and kidneys, creating a self-reinforcing cycle.
Diabetes – a leading cause of both CKD and cardiovascular disease; high blood sugar damages blood vessels and organs.
Obesity – increases the workload on both the heart and kidneys.
Smoking – accelerates blood vessel damage and raises the risk of both diseases.
High cholesterol – leads to plaque buildup that narrows arteries feeding the heart and kidneys.
Because these conditions travel together, doctors increasingly describe them as part of a single picture called cardiovascular-kidney-metabolic (CKM) syndrome (Ndumele et al., American Heart Association Scientific Statement, 2023).
2. How CKD Increases Heart Disease Risk
A. Higher and harder-to-control blood pressure. When kidneys can't regulate blood pressure well, hypertension develops. Over time, high pressure stiffens blood vessels and forces the heart to work harder, setting the stage for heart failure and stroke.
B. Fluid overload and heart failure. Kidneys that filter poorly may retain excess fluid. This extra fluid can cause swelling (edema), raise blood pressure, and strain the heart, increasing the risk of heart failure.
C. Buildup of waste products. As kidney function declines, waste products (uremic toxins) build up in the blood. These promote inflammation and blood vessel damage, contributing to heart attacks and strokes (Matsushita et al., Nature Reviews Nephrology, 2022).
D. Calcification of blood vessels (hardening of the arteries). CKD upsets the balance of calcium and phosphate, causing arteries to stiffen and narrow, which raises heart disease risk, sometimes even in younger patients (Düsing et al., Journal of Molecular Medicine, 2021).
E. Anemia. Many people with CKD develop anemia (low red blood cell count), which lowers oxygen delivery and makes the heart work harder.
How to Protect Your Heart When You Have CKD
Much of your risk is modifiable. Here's what makes the biggest difference:
1. Control your blood pressure. Guidelines recommend a target below 130/80 mmHg, and some (KDIGO) suggest aiming for a systolic pressure under 120 mmHg when it can be reached safely. Your doctor will set the right goal for you (KDIGO Blood Pressure Guideline, 2021; AHA/ACC High Blood Pressure Guideline, 2025).
2. Ask about kidney- and heart-protective medications. Two medication groups are now foundational for many people with CKD:
ACE inhibitors or ARBs lower blood pressure and protect the kidneys, especially when protein is present in the urine.
SGLT2 inhibitors (such as dapagliflozin or empagliflozin) reduce the risk of both heart and kidney complications, even in many people without diabetes.
Depending on your situation, your doctor may add other agents such as finerenone or a GLP-1 receptor agonist (Herrington et al., Lancet, 2026; Navaneethan et al., Journal of the American Society of Nephrology, 2026).
3. Manage blood sugar if you have diabetes. Keeping glucose in a healthy range slows both kidney and heart damage.
4. Eat a heart-healthy, kidney-friendly diet.
Limit sodium (aim for under about 2,000–2,300 mg per day) to help control blood pressure and fluid.
Emphasize vegetables, fruits, and whole grains, with more plant-based protein (limit potassium- or phosphorus-rich foods only if your care team advises).
Limit processed foods and sugar-sweetened drinks.
A DASH-style or Mediterranean-style pattern is a reasonable framework (Kalantar-Zadeh et al., Lancet, 2021).
5. Reach and keep a healthy weight. Even modest weight loss can improve blood pressure and lipid levels.
6. Exercise regularly. Aim for at least 150 minutes of moderate activity per week (such as brisk walking or cycling), tailored to your abilities.
7. Quit smoking. Stopping smoking benefits both your heart and kidneys and lowers overall mortality risk.
8. Manage your cholesterol. Statins are recommended for most adults with CKD to reduce heart disease risk; ask your doctor whether one is right for you.
9. Handle fluids based on your doctor's advice. For most people with earlier-stage CKD, normal thirst-guided drinking is fine. Strict fluid limits mainly apply to advanced kidney disease, fluid overload, or dialysis: follow your care team's specific guidance rather than a one-size-fits-all rule.
10. Monitor your kidney and heart health.
Get routine blood and urine tests to check kidney function (including urine protein).
Track blood pressure and cholesterol.
Seek prompt care for shortness of breath, new swelling, or chest pain.
Why Awareness Matters
Heart disease is the leading cause of death in people with CKD, yet many are unaware of their elevated risk until problems appear. Regular check-ups, early treatment, and consistent lifestyle changes meaningfully improve outcomes.
Key Takeaways
CKD and heart disease are tightly linked, having one raises your risk of the other.
High blood pressure, fluid overload, waste-product buildup, vascular calcification, and anemia all drive up heart disease risk in CKD.
Proven protection includes blood pressure control, ACE inhibitors/ARBs and SGLT2 inhibitors, statins, a low-sodium heart-healthy diet, exercise, weight management, and quitting smoking.
Regular monitoring and early treatment can prevent serious complications.
Acting promptly offers the best opportunity to disrupt the connection between kidney and heart disease, promoting a longer, healthier life.
At Preventiononly, we focus on identifying risks for kidney and heart disease and addressing them sooner than most traditional healthcare programs, which often lack the time or financial motivation. We approach heart disease (or risk) within the heart-kidney-metabolism continuum, rather than in isolation. Membership is now available to Ohio residents, and our self-help app is accessible worldwide. To explore our membership plans, visit www.preventiononly.com/membership, and to download our app, go to www.preventiononly.com/theapp.
References
2021 ESC Guidelines on Cardiovascular Disease Prevention in Clinical Practice. Visseren FLJ, Mach F, Smulders YM, et al. European Heart Journal. 2021;42(34):3227-3337. doi:10.1093/eurheartj/ehab484.
Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review. Sarnak MJ, Amann K, Bangalore S, et al. Journal of the American College of Cardiology. 2019;74(14):1823-1838. doi:10.1016/j.jacc.2019.08.1017.
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association. Ndumele CE, Neeland IJ, Tuttle KR, et al. Circulation. 2023;148(20):1636-1664. doi:10.1161/CIR.0000000000001186.
Cardiovascular Disease in Chronic Kidney Disease. Marx-Schütt K, Cherney DZI, Jankowski J, et al. European Heart Journal. 2025;46(23):2148-2160. doi:10.1093/eurheartj/ehaf167.
Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease. Matsushita K, Ballew SH, Wang AY, et al. Nature Reviews. Nephrology. 2022;18(11):696-707. doi:10.1038/s41581-022-00616-6.
Chronic Kidney Disease. Kalantar-Zadeh K, Jafar TH, Nitsch D, Neuen BL, Perkovic V. Lancet (London, England). 2021;398(10302):786-802. doi:10.1016/S0140-6736(21)00519-5.
Chronic Kidney Disease. Herrington WG, Judge PK, Grams ME, Wanner C. Lancet (London, England). 2026;407(10523):90-104. doi:10.1016/S0140-6736(25)01942-7.
Association of chronic kidney disease and cardiovascular disease risk with all-cause mortality: an interaction, joint and mediation analysis in Chinese adults. Li Y, Shi Y, Zhu B, et al. BMC Public Health. 2025;25(1):1685. doi:10.1186/s12889-025-22924-9.
Vascular Pathologies in Chronic Kidney Disease: Pathophysiological Mechanisms and Novel Therapeutic Approaches. Düsing P, Zietzer A, Goody PR, et al. Journal of Molecular Medicine (Berlin, Germany). 2021;99(3):335-348. doi:10.1007/s00109-021-02037-7.
2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Jones DW, Ferdinand KC, Taler SJ, et al. Journal of the American College of Cardiology. 2025;86(18):1567-1678. doi:10.1016/j.jacc.2025.05.007.
KDIGO 2021 Clinical Practice Guideline on the Management of Blood Pressure (BP) in Chronic Kidney Disease (CKD). Pierre Ronco, Brad Rovin, Detlef Schlöndorff, et al. Kidney Disease: Improving Global Outcomes.
Executive Summary of the ASN Kidney Health Guidance on the Cardiovascular‑Kidney‑Metabolic Syndrome. Navaneethan SD, Rifkin B, Mottl AK, on behalf of the ASN Kidney Health Workgroup on the Cardiovascular-Kidney-Metabolic Syndrome. Journal of the American Society of Nephrology : JASN. 2026;:00001751-990000000-01120. doi:10.1681/ASN.0000001230.
Detecting and managing the patient with chronic kidney disease in primary care: A review of the latest guidelines. Mayne KJ, Hanlon P, Lees JS. Diabetes, Obesity & Metabolism. 2024;26 Suppl 6:43-54. doi:10.1111/dom.15625.
Chronic kidney disease in primary care: risk of cardiovascular events, end stage kidney disease and death. Borg R, Kriegbaum M, Grand MK, et al. BMC Primary Care. 2023;24(1):128. doi:10.1186/s12875-023-02077-7.
Cardiovascular–kidney–metabolic syndrome: a comprehensive review of pathophysiology, epidemiology, diagnosis, and management. Jankauskas SS, Komici K, Varzideh F, et al. Cardiovascular Diabetology. 2026;25(1):182. doi:10.1186/s12933-026-03177-1.
Uraemic solutes as therapeutic targets in CKD-associated cardiovascular disease. Ravid JD, Kamel MH, Chitalia VC. Nature Reviews. Nephrology. 2021;17(6):402-416. doi:10.1038/s41581-021-00408-4.
Treatment of Hypertension in Chronic Kidney Disease. Kalaitzidis RG, Elisaf MS. Current Hypertension Reports. 2018;20(8):64. doi:10.1007/s11906-018-0864-0.
Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations. Law JP, Pickup L, Pavlovic D, Townend JN, Ferro CJ. Journal of Human Hypertension. 2023;37(1):1-19. doi:10.1038/s41371-022-00751-4.
Comments